BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 30946309)

  • 21. Efficacy of Nonsteroidal Anti-inflammatory Drug Prophylaxis for Heterotrophic Ossification in Hip Arthroscopy: A Systematic Review.
    Yeung M; Jamshidi S; Horner N; Simunovic N; Karlsson J; Ayeni OR
    Arthroscopy; 2016 Mar; 32(3):519-25. PubMed ID: 26432432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-steroidal anti-inflammatory drugs for heterotopic ossification prophylaxis after total hip arthroplasty: a systematic review and meta-analysis.
    Joice M; Vasileiadis GI; Amanatullah DF
    Bone Joint J; 2018 Jul; 100-B(7):915-922. PubMed ID: 29954195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heterotopic ossification after total hip arthroplasty: When is development completed?
    Willburger RE; Brinkhoff F; Nottenkämper J; Krapp J; Oberberg S
    J Orthop Surg Res; 2022 Mar; 17(1):147. PubMed ID: 35248082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: A network meta-analysis.
    Cai L; Wang Z; Luo X; She W; Zhang H
    Int J Surg; 2019 Feb; 62():74-85. PubMed ID: 30615954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiotherapy vs. nonsteroidal anti-inflammatory drugs for the prevention of heterotopic ossification after major hip procedures: a meta-analysis of randomized trials.
    Pakos EE; Ioannidis JP
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):888-95. PubMed ID: 15465207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study on the prevention of heterotopic ossification after total hip arthroplasty by Xiaozhong Zhitong].
    Liu HP; Li YJ; Wang CX; Li SH; Zhao ZW; Wang JH
    Zhongguo Gu Shang; 2011 Oct; 24(10):857-60. PubMed ID: 22097138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of heterotopic ossification about the hip: final results of two randomized trials in 410 patients using either preoperative or postoperative radiation therapy.
    Seegenschmiedt MH; Keilholz L; Martus P; Goldmann A; Wölfel R; Henning F; Sauer R
    Int J Radiat Oncol Biol Phys; 1997 Aug; 39(1):161-71. PubMed ID: 9300751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The incidence of heterotopic ossification after hip arthroscopy.
    Bedi A; Zbeda RM; Bueno VF; Downie B; Dolan M; Kelly BT
    Am J Sports Med; 2012 Apr; 40(4):854-63. PubMed ID: 22268230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hip Arthroscopy and Heterotopic Ossification: Is NSAID Prophylaxis Justified? Commentary on an article by James T. Beckmann, MD, MS, et al.: "Effect of Naproxen Prophylaxis on Heterotopic Ossification Following Hip Arthroscopy: A Double-Blind Randomized Placebo-Controlled Trial".
    Løken S
    J Bone Joint Surg Am; 2015 Dec; 97(24):e80. PubMed ID: 26677244
    [No Abstract]   [Full Text] [Related]  

  • 30. Aspirin decreases heterotopic ossification after hip resurfacing.
    Nunley RM; Zhu J; Clohisy JC; Barrack RL
    Clin Orthop Relat Res; 2011 Jun; 469(6):1614-20. PubMed ID: 21409458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of ibuprofen and indomethacin as prophylaxis of heterotopic ossification: a comparative study.
    Schneider J; Maffulli N; Eschweiler J; Bell A; Hildebrand F; Migliorini F
    Sci Rep; 2023 Nov; 13(1):20210. PubMed ID: 37980449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of Ibuprofen after Total Hip Arthroplasty to Prevent Heterotopic Ossification: Systematic Review and Meta-Analysis.
    Tariq MA; Ahmed B; Shaikh S; Amin H; Ali SU
    Rev Bras Ortop (Sao Paulo); 2023 Jun; 58(3):378-387. PubMed ID: 37396093
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib and heterotopic bone formation after total hip arthroplasty.
    Lavernia CJ; Contreras JS; Villa JM; Rossi MD
    J Arthroplasty; 2014 Feb; 29(2):390-2. PubMed ID: 23927909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.
    Xue D; Zheng Q; Li H; Qian S; Zhang B; Pan Z
    Int Orthop; 2011 Jan; 35(1):3-8. PubMed ID: 19830425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similar effects of rofecoxib and indomethacin on the incidence of heterotopic ossification after hip arthroplasty.
    van der Heide HJ; Rijnberg WJ; Van Sorge A; Van Kampen A; Schreurs BW
    Acta Orthop; 2007 Feb; 78(1):90-4. PubMed ID: 17453398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined radiotherapy and indomethacin for the prevention of heterotopic ossification after total hip arthroplasty.
    Pakos EE; Stafilas KS; Tsekeris PG; Politis AN; Mitsionis G; Xenakis TA
    Strahlenther Onkol; 2009 Aug; 185(8):500-5. PubMed ID: 19652932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
    Legenstein R; Bösch P; Ungersböck A
    Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of NSAIDs versus radiotherapy for heterotopic ossification prophylaxis following total hip arthroplasty in high-risk patients: a systematic review and meta-analysis.
    Shapira J; Yelton MJ; Chen JW; Rosinsky PJ; Maldonado DR; Meghpara M; Lall AC; Domb BG
    Hip Int; 2022 Sep; 32(5):576-590. PubMed ID: 33736491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative versus postoperative radiotherapy for prevention of heterotopic ossification (HO): first results of a randomized trial in high-risk patients.
    Seegenschmiedt MH; Martus P; Goldmann AR; Wölfel R; Keilholz L; Sauer R
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):63-73. PubMed ID: 8083130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
    Gebuhr PH; Wilbek H; Soelberg M
    Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.